We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+6.87%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$184M
AUM Growth
-$21.4M
(-10%)
Cap. Flow
-$46.6M
Cap. Flow
% of AUM
-25.37%
Top 10 Holdings %
Top 10 Hldgs %
35.95%
Holding
217
New
29
Increased
61
Reduced
33
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microchip Technology
MCHP
|
+$5.09M |
| 2 |
GSI Technology
GSIT
|
+$2.17M |
| 3 |
Annovis Bio
ANVS
|
+$1.48M |
| 4 |
Clene
CLNN
|
+$1.45M |
| 5 |
Karyopharm Therapeutics
KPTI
|
+$1.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adtran
ADTN
|
+$4.21M |
| 2 |
Silicom
SILC
|
+$2.81M |
| 3 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
+$2.59M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$2.17M |
| 5 |
Carvana
CVNA
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.84% |
| 2 | Healthcare | 16.62% |
| 3 | Financials | 6.45% |
| 4 | Real Estate | 2.82% |
| 5 | Consumer Staples | 1.78% |
Similar funds
VL
SP
OGC
PE
RL
AIIC
LGM
SCA
Worth Venture Partners's Q2 2023 Portfolio in Review
As of Q2 2023, Worth Venture Partners held 217 positions worth $184M, down 10% from $205M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Worth Venture Partners withdrew a net $46.6M in Q2 2023, closing 50 positions and reducing 33 holdings. Its most notable exit was Adtran, an estimated $4.21M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in GSI Technology worth $2.76M.
- Worth Venture Partners's largest Q2 2023 buy was GSI Technology: 499,400 shares worth $2.76M.
- Worth Venture Partners added most to Microchip Technology in Q2 2023, an estimated $5.09M increase.
- Worth Venture Partners's biggest Q2 2023 reduction was Marinus Pharmaceuticals, Inc, cutting an estimated $2.59M.
- Worth Venture Partners fully exited Adtran in Q2 2023, selling an estimated $4.21M.
- Worth Venture Partners's ten largest holdings make up 36% of its $184M portfolio in Q2 2023.
- Worth Venture Partners opened 29 new positions and closed 50 in Q2 2023.
- Worth Venture Partners's portfolio value fell 10% quarter-over-quarter to $184M.
Based on Worth Venture Partners's 13F filing for Q2 2023, filed 14 Aug 2023.